Elevated expression of activated forms of Neu/ErbB-2 and ErbB-3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancer
- 15 April 1999
- journal article
- Published by Springer Nature in The EMBO Journal
- Vol. 18 (8), 2149-2164
- https://doi.org/10.1093/emboj/18.8.2149
Abstract
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.Keywords
This publication has 86 references indexed in Scilit:
- A novel splice variant ofHER2 with increased transformation activityMolecular Carcinogenesis, 1998
- The Relationship between Human Epidermal Growth-like Factor Receptor Expression and Cellular Transformation in NIH3T3 CellsJournal of Biological Chemistry, 1996
- Activated neu Induces Rapid Tumor ProgressionJournal of Biological Chemistry, 1996
- Requirement for Phosphatidylinositol-3 Kinase in the Prevention of Apoptosis by Nerve Growth FactorScience, 1995
- c-erbB-3 and c-erbB-2 protein expression in node-negative breast carcinoma—an immunocytochemical studyEuropean Journal Of Cancer, 1994
- c‐erbB‐3 protein expression in human breast cancer: comparison with other tumour variables and survivalHistopathology, 1994
- Early and multifocal tumors in breast, salivary, Harderian and epididymal tissues developed in MMTY-Neu transgenic miceCancer Letters, 1992
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987
- Tyrosine Kinase Receptor with Extensive Homology to EGF Receptor Shares Chromosomal Location with neu OncogeneScience, 1985
- Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cellsNature, 1984